Karachi: Global Marketing Services (GMS) has maintained its strong position in the clinical and medical laboratory equipment sector, as confirmed by the latest assessment from PACRA, the Pakistan Credit Rating Agency Limited. The company has recently undergone corporatization, consolidating its clinical and medical divisions under a single entity, which has enhanced its operational efficiency and market presence.

According to PACRA, GMS's success is bolstered by the growth trajectory of Pakistan's medical devices and diagnostics market, spurred by increased public awareness and improved accessibility to advanced diagnostic procedures. The 2026-27 budget has provided significant relief to the sector by abolishing the value-added tax on imported finished pharmaceutical and diagnostic products and reducing customs duties, which is expected to alleviate cost pressures on distributors like GMS.

The company's financial performance has shown marked improvements, with sales reaching approximately PKR 5,210 million in the first nine months of FY26 compared to PKR 5,282 million for the entire FY25. Profitability margins are also on the rise, with gross margins increasing to around 26.7% and net margins strengthening to approximately 10.1%. This growth is attributed to effective financial management and a robust partnership network with renowned global principals.

Despite its reliance on imports and exposure to currency fluctuations, GMS mitigates risks through long-term contracts and pricing strategies aligned with USD exchange rates. The company's governance structure, while functional, requires enhancement through formal board committees and independent oversight to support its continued growth and financial stability.